SCHEMBL14166102

SCHEMBL14166102

NC(c1ccccc1)c1ccccc1OC(=O)C(O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.43
MAPK1 P28482 1/20 0.43
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 1/20 0.37
HSD17B10 Q99714 1/20 0.37
HPGD P15428 1/20 0.37
CHRM2 P08172 2/20 0.36
CHRM1 P11229 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM3 P20309 1/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP1A2 P05177 1/20 0.36
PKM P14618 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14166103 0.78 LMNA (0.46) LMNAMAPK1CES2CES1CYP2D6
SCHEMBL31107079 0.76 LMNA (0.47) LMNAMAPK1CES2CES1CYP2D6
SCHEMBL14166148 0.74 L3MBTL1 (0.42) LMNAMAPK1CES2CES1CYP2D6
SCHEMBL14166147 0.74 L3MBTL1 (0.42) LMNAMAPK1CES2CES1CYP2D6
SCHEMBL9719141 0.73 DPP4 (0.55) LMNAADRA2AADRA2C
SCHEMBL11119110 0.72 ATM (0.58) LMNAMAPK1CES2CES1CYP2D6
SCHEMBL2246434 0.72 ATM (0.58) LMNAMAPK1CES2CES1CYP2D6
SCHEMBL20241687 0.72 IDO1 (0.59) TDP1NPSR1KMT2AIDO1TDO2
SCHEMBL5690338 0.72 ATM (0.58) LMNAMAPK1CES2CES1CYP2D6
SCHEMBL9680973 0.72 IDO1 (0.59) TDP1NPSR1KMT2AIDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718280-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Chiesi Farmaceutici S.p.A. (IT) 2014-04-16 EP disclosed
WO-2012168359-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2012-12-13 WO disclosed